Karyopharm Therapeutics, Inc. (KPTI)
8.58
-0.36
(-4.03%)
USD |
NASDAQ |
Feb 13, 16:00
8.60
+0.02
(+0.23%)
After-Hours: 20:00
Karyopharm Therapeutics EPS Diluted (Quarterly) : -5.708 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Baxter International, Inc. | -2.160 |
| Bruker Corp. | 0.0977 |
| Catalyst Pharmaceuticals, Inc. | 0.4153 |
| Agios Pharmaceuticals, Inc. | -1.852 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -102.20M |
| Revenue (Quarterly) | 34.08M |
| Total Expenses (Quarterly) | 136.28M |
| Enterprise Value | 309.10M |
| Gross Profit Margin (Quarterly) | 95.65% |
| Profit Margin (Quarterly) | -299.9% |
| Earnings Yield | -193.7% |
| Normalized Earnings Yield | -165.30 |